SRC
Drug & target - TTD
NameType of TargetSynonymsDiseaseDrugsInhibitorAntibody
Proto-oncogene tyrosine-protein kinase SRCSuccessful targetC-Src;C-src TK;C-SRC tyrosine kinase;P60-Src;Pp60(src);Src tyrosine kinase;Tyrosine kinase;Tyrosine kinase (pp60(src))Breast cancer;Cancer;OsteoporosisBosutinib;Herbimycin A;KX01;KX2-361;SKI-758;KX-02;AZD0530;Dasatinib;Dasatinib;PD173074RU78300;Y-c[D-Pen-(2R,3R)-2-Me-(2')Nal-GSFC]KR-NH2;SKS-927;RU78262;Bosutinib;BAS-01373578;BAS-01047655;RU78191;Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Phe(4-NO2);Herbimycin A;Y-c[D-Pen-(2')Nal-GSFC]KR-NH2;Y-c[D-Pen-D-(2')Nal-GSFC]KR-NH2;Cyclo[Ac-Cys-Ile-Phe]-Lys-Tyr-Tyr;Y-c[D-Pen-(2S,3S)-2-Me-(2')Nal-GSFC]KR-NH2;K00244;2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE;NG-25;PD-174265;N-Phenyl-5-phenylimidazo[1,5-a]pyrazin-8-amine;Ac-Cys-Ile-Tyr-Lys-Phe(4-CN)-Tyr;PD-0180970;Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Tyr];BAS-4844343;BAS-00672722;BMS-279700;Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Phe(4-NO2);Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2;compound 2;PAS219;compound 8h;KX01;Ac-Cys-Ile-Tyr-Lys-Phe(4-I)-Tyr;Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Tyr;PD-0179483;Y-c[D-Pen-(2R,3S)-2-Me-(2')Nal-GSFC]KR-NH2;Ac-Cys-Ile-Tyr-Lys-Phe(4-Cl)-Tyr;AG-1879;Oxalic Acid;3-(3-aminobenzo[e][1,2,4]triazin-7-yl)phenol;4-Chloro-5,7-diphenyl-7H-pyrrolo[2,3-d]pyrimidine;AP-24226;N6-Benzyl Adenosine-5'-Diphosphate;BAS-00387347;CGP-191;SU 6656;PD-0173952;RU85493;Ac-Cys-Ile-Tyr-Lys-Phe(4-N3)-Tyr;BAS-450225;KX2-361;CGP-62464;PD-0166326;TG-100435;CGP 77675;JNJ-10198409;RU79073;RU81843;RU78783;SKI-758;RU82197;A-420983;SBB007833;Phosphonotyrosine;Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu;Ac-Cys-Ile-Tyr-Lys-Tyr-Phe(4-NO2);A-770041;RU90395;RU79256;ISO24;Ac-Cys-Ile-Phe(4-NO2)-Lys-Phe(4-NO2)-Tyr;RU79072;5,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol;AP-24163;AP22408;BAS-01047341;PASBN;BAS-00387275;NM-PP1;WH-4-023;Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr;RU82129;BAS-0338872;PD166285;Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2;N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE;RU82209;7-(naphthalen-2-yl)benzo[e][1,2,4]triazin-3-amine;KX-02;AZD0530;Dasatinib;DPI59;Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Phe];Y-c[D-Pen-(2S,3R)-2-Me-(2')Nal-GSFC]KR-NH2;Phenylphosphate;PD-0173958;RU78299;Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Tyr-Phe;PD-0173955;Cysteine Sulfenic Acid;RU85053;PD173074;BAS-0338868;RU84687;PD-0173956;BAS-09534324;BAS-00387328;PP121;Glu-Pro-Gln-F2Pmp-Glu-Glu-Ile-Pro-Ile-Tyr-Leu;RU83876
Src tyrosine kinaseResearch targetProto-oncogene tyrosine-protein kinase Src;Proto-oncogene c-Src;pp60c-src;p60-Src;SRCColon cancer;Cancer;Brain cancer;Glioblastoma
Drug & target - KPID
CNumberInhibitorTargetCASInChI KeyPubChem CID
21 NA-PP1 (PP1 Analog)Src221243-82-9XSHQBIXMLULFEV-UHFFFAOYSA-N4877
31 NM-PP1 (PP1 Analog II)Src221244-14-0GDQXJQSQYMMKRA-UHFFFAOYSA-N5154691
329Bosutinibsrc380843-75-4UBPYILGKFZZVDX-UHFFFAOYSA-N5328940
89PP1Src172889-26-8ZVPDNRVYHLRXLX-UHFFFAOYSA-N1400
90PP2Src172889-27-9PBBRWFOVCUAONR-UHFFFAOYSA-N4878
157PP3Src5334-30-5KKDPIZPUTYIBFX-UHFFFAOYSA-N4879
278Saracatinib (AZD0530)Src379231-04-6OUKYUETWWIPKQR-UHFFFAOYSA-N10302451
115SRC Inhibitor 1Src179248-59-0DMWVGXGXHPOEPT-UHFFFAOYSA-N1474853
119SU-6656Src330161-87-0LOGJQOUIVKBFGH-YBEGLDIGSA-N5312137
Drug & target - GRAC
SRC proto-oncogene, non-receptor tyrosine kinase enzyme 619 Src family 2206 20q12-q13
Drug & target - PDTD
Ensembl_gene_ID UniProt ID PDB Code
ENSG00000197122.11 P12931 1YOL